Abiola JO, Oluyemi AA, Idowu OT, Oyinloye OM, Ubah CS, Owolabi OV, Somade OT, Onikanni SA, Ajiboye BO, Osunsanmi FO, et al
it only affects how much of the drug is absorbed into your system at that specific moment
A 2026 systematic review of 37 studies found that discontinuing treatment was associated with weight regain of roughly half a pound per month, with researchers projecting a return to baseline weight within about 1.5 years
Widhyastuti, and D
Similarly, the highly anticipated EVOKE and EVOKE+ phase 3 trials of oral semaglutide in early Alzheimers disease reported in November 2025 that semaglutide failed to meet its primary endpoints : while it reduced several AD-related biomarkers by up to 10%, these changes did not translate into cognitive or functional benefit ( [72] )
Semaglutide is particularly effective for those with obesity or those who have weight-related health conditions